Bank of America’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-978,062
| Closed | -$162M | – | 8696 |
|
|
2021
Q2 | $162M | Buy |
978,062
+615,547
| +170% | +$103M | 0.02% | 726 |
|
|
2021
Q1 | $55.6M | Buy |
362,515
+212,560
| +142% | +$28.9M | 0.01% | 1221 |
|
|
2020
Q4 | $18.8M | Buy |
149,955
+85,099
| +131% | +$9.52M | ﹤0.01% | 1955 |
|
|
2020
Q3 | $6.58M | Sell |
64,856
-49,632
| -43% | -$5.06M | ﹤0.01% | 2654 |
|
|
2020
Q2 | $11.1M | Sell |
114,488
-155,457
| -58% | -$14.5M | ﹤0.01% | 2118 |
|
|
2020
Q1 | $22.4M | Buy |
269,945
+72,004
| +36% | +$7.02M | ﹤0.01% | 1435 |
|
|
2019
Q4 | $22M | Buy |
197,941
+18,002
| +10% | +$1.85M | ﹤0.01% | 1806 |
|
|
2019
Q3 | $17.9M | Sell |
179,939
-30,726
| -15% | -$3.05M | ﹤0.01% | 1931 |
|
|
2019
Q2 | $20.9M | Sell |
210,665
-32,808
| -13% | -$3.13M | ﹤0.01% | 1848 |
|
|
2019
Q1 | $26.9M | Buy |
243,473
+1,725
| +0.7% | +$180K | ﹤0.01% | 1577 |
|
|
2018
Q4 | $22.2M | Sell |
241,748
-118,148
| -33% | -$12M | ﹤0.01% | 1579 |
|
|
2018
Q3 | $39.7M | Sell |
359,896
-11,470
| -3% | -$1.19M | 0.01% | 1273 |
|
|
2018
Q2 | $34.7M | Sell |
371,366
-11,767
| -3% | -$1.01M | 0.01% | 1358 |
|
|
2018
Q1 | $31.8M | Buy |
383,133
+127,040
| +50% | +$11.3M | 0.01% | 1402 |
|
|
2017
Q4 | $23.3M | Sell |
256,093
-16,270
| -6% | -$1.35M | ﹤0.01% | 1680 |
|
|
2017
Q3 | $20.7M | Buy |
272,363
+84,327
| +45% | +$6.37M | ﹤0.01% | 1849 |
|
|
2017
Q2 | $14.1M | Sell |
188,036
-29,575
| -14% | -$2.05M | ﹤0.01% | 2047 |
|
|
2017
Q1 | $14.2M | Buy |
217,611
+83,324
| +62% | +$4.91M | ﹤0.01% | 2076 |
|
|
2016
Q4 | $7.4M | Sell |
134,287
-17,470
| -12% | -$959K | ﹤0.01% | 2573 |
|
|
2016
Q3 | $8.58M | Buy |
151,757
+35,256
| +30% | +$1.73M | ﹤0.01% | 2373 |
|
|
2016
Q2 | $4.87M | Sell |
116,501
-7,925
| -6% | -$365K | ﹤0.01% | 2818 |
|
|
2016
Q1 | $5.32M | Buy |
124,426
+45,802
| +58% | +$1.94M | ﹤0.01% | 2724 |
|
|
2015
Q4 | $3.56M | Buy |
78,624
+4,779
| +6% | +$201K | ﹤0.01% | 3285 |
|
|
2015
Q3 | $2.87M | Buy |
73,845
+34,106
| +86% | +$1.37M | ﹤0.01% | 3428 |
|
|
2015
Q2 | $1.44M | Buy |
39,739
+15,104
| +61% | +$478K | ﹤0.01% | 3789 |
|
|
2015
Q1 | $710K | Buy |
24,635
+23,344
| +1,808% | +$651K | ﹤0.01% | 4038 |
|
|
2014
Q4 | $31K | Buy |
+1,291
| New | +$29.1K | ﹤0.01% | 6591 |
|
Other funds holding PRAH
Bank of America's PRAH Position: Q3 2021 in Review
Bank of America sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 978,062 shares — an estimated $162M sold.
Bank of America first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $162M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Bank of America reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Bank of America sold 978,062 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $162M.
- Bank of America first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- Bank of America's PRA Health Sciences, Inc. position peaked at $162M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Bank of America's 13F filing for Q3 2021, filed 15 Nov 2021.